Welcome

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.

Events

07/17/2024 | Biomarkers in psychyatry
Join us in todays SESSION: Understanding Biomarkers in Psychiatry: from clinical... More

05/21/2024 | Bioequity Europe 2024
Aromics will be present at virtual event of the Bioequity Europe 2024 conference... More

News

07/17/2024 | Aromics joins the working group of Chemical Exposomes at SOCSA
Our CEO, Dr. Carmen Plasencia, has joined the working group of Chemical Exposomes... More

06/24/2024 | Completed IDEA2 MIT program
7 months of intense mentoring from the world’s best at MIT: finished ✔ Our... More